z-logo
Premium
An easy schedule for postsurgical radioiodine administration in newly diagnosed differentiated thyroid carcinoma patients
Author(s) -
Lupoli Gelsy A.,
Poggiano Maria R.,
Panico Annalisa,
Granieri Luciana,
Lupoli Roberta,
Cacciapuoti Marianna,
Lupoli Giovanni
Publication year - 2013
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.12004
Subject(s) - medicine , group b , thyroid carcinoma , group a , thyroidectomy , thyroid , radioiodine therapy , gastroenterology , endocrinology , urology , surgery
Summary Objective To validate the simplest approach to preparing patients with differentiated thyroid carcinoma ( DTC ) for 131 I ‐administration ( 131 I ‐ A ), minimizing the impact of hypothyroidism. Design Panel study. Patients Ninety patients with DTC were enrolled in the study. Sixty (Group A) underwent total thyroidectomy ( TT ); L‐T4 was not administered in preparation for 131 I ‐ A planned for 3 weeks later. Thirty patients (Group B) with previous TT and 131 I ‐ A stopped L‐T4 in preparation for clinical evaluation, including whole‐body scanning ( WBS )/radioiodine therapy during thyrotrophin ( TSH ) stimulation planned for 3 weeks (or more) later. Measurements Thyrotrophin was measured the day before TT for group A, during L‐T4 for group B (baseline‐time 1) and then every week until it reached ≥30 mIU/l (time 2). Quality of life ( Q o L ) was evaluated by Billewicz index. Results At week 3, 100% of patients in group A and 56·6% of group B exceeded TSH  > 30 mIU/l. In group B, the cut‐off was achieved in four patients at the fourth week ( TSH 38·6 ± 8·7 mIU/l), in 3 at the fifth (53·2 ± 3) and in 6 at the sixth (42·3 ± 6·1). From time 1 to time 2, total Q o L scores were less affected in group A (percentage decrease: 105%) than in group B (218%). At time 2, the total score was >+19 in group A in 46 patients and in 30 in group B. In group A, TSH levels in the higher tertile of Q o L (61 ± 6 mIU/l) were not different from those in the lower tertile (62·3 ± 11·1)( P  > 0·1); similar results were seen in group B (69·3 ± 13·3 vs 62·9 ± 13·1)( P  > 0·1). There was a positive correlation between the time to obtain TSH  ≥ 30 mIU/l and total Q o L scores. Conclusions Quality of life scores were not affected by thyrotrophin was measured the day before TT levels as absolute values. A longer time to obtain TSH  ≥ 30 mIU/l was positively correlated with worse scores of Q o L . We suggest 3 weeks without therapy can be used as an easy schedule in patients who undergo TT for DTC.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here